Category - Executive Moves

Executive Moves

Cellares names leading bioethicist Dr. Ezekiel Emanuel to board of advisors

Ezekiel Emanuel Closely-held cell therapy manufacturer, Cellares, appointed Ezekiel Emanuel, M.D. and Ph.D., to its board of advisors. Dr. Emanuel is a bioethicist and currently vice provost for global initiatives, the...

November 16, 2021

Executive Moves

GeneTether bolsters management team to support growth

Closely-held GeneTether, a genome editing technology company, named Roland Boivin as CEO, Jean Jen as CFO and Peter Sampson, Ph.D., as VP of research and development. The appointments are intended to further position...

October 19, 2021

Executive Moves

Daniel Pearlstein joins POINT Biopharma in corporate strategy

Daniel Pearlstein was named associate director, corporate strategy, of POINT Biopharma (NASDAQ:PNT), which debuted on the Nasdaq Capital Market on July 1, 2021. Mr. Pearlstein was formerly EVP for...

September 27, 2021

Executive Moves

RNADD adds renowned pro sports team physician Michael Farber to advisory board

Michael Farber Closely-held RNA Disease Diagnostics appointed board-certified internist and professional sports physician, Michael Farber, M.D., to its advisory board. Dr. Farber is the medical director of executive...

September 2, 2021

Executive Moves

iBio names biotech veteran Chip Clark to the board

William (Chip) Clark iBio (NYSE:IBIO) appointed William (Chip) Clark to the board, effective immediately. Mr. Clark has more than 30 years of biotechnology and pharmaceutical experience, with a focus on business...

August 26, 2021

Executive Moves

IntelGenx strengthens board with atai appointments of Dr. Srinivas Rao and Frank Stegert

IntelGenx Technologies (TSXV:IGX; OTCQB:IGXT) named Dr. Srinivas (Srini) Rao, M.D., Ph.D., and Frank Stegert to the board, reflecting a previously disclosed purchaser rights agreement with atai Life Sciences AG. With...

August 4, 2021

Executive Moves

EyeGate Pharma names Brian Strem as president and CEO

Brian Strem EyeGate Pharmaceuticals (NASDAQ:EYEG) appointed Brian Strem, Ph.D., as president, CEO and a director, effective immediately. He replaces acting CEO, Franz Obermayr, Ph.D., who reassumes his position as...

July 28, 2021

Executive Moves

Kyle Mikson joins Canaccord Genuity as director, senior equity research

Kyle Mikson Canaccord Genuity appointed Kyle Mikson as a director, senior equity research analyst covering the life science tools and diagnostics sector. Mr. Mikson will focus on expanding the firm’s footprint on...

July 9, 2021

Executive Moves

Healthcare veteran Richard Ganz joins RNA Disease Diagnostics board

Closely-held RNA Disease Diagnostics appointed Robert Ganz, a healthcare veteran with more than 40 years of executive experience in venture-backed startups and international healthcare companies, to the board. Mr. Ganz...

July 8, 2021

Executive Moves

Q32 Bio names Adam Cutler as CFO

Adam Cutler Closely-held Q32 Bio appointed Adam Cutler as chief financial officer, with responsibility for all aspects of its financial strategy and operations. Mr. Cutler has more than 20 years of experience in...

July 7, 2021

Category - Executive Moves

Cellares names leading bioethicist Dr. Ezekiel Emanuel to board of advisors

GeneTether bolsters management team to support growth

Daniel Pearlstein joins POINT Biopharma in corporate strategy

RNADD adds renowned pro sports team physician Michael Farber to advisory board

iBio names biotech veteran Chip Clark to the board

IntelGenx strengthens board with atai appointments of Dr. Srinivas Rao and Frank Stegert

EyeGate Pharma names Brian Strem as president and CEO

Kyle Mikson joins Canaccord Genuity as director, senior equity research

Healthcare veteran Richard Ganz joins RNA Disease Diagnostics board

Q32 Bio names Adam Cutler as CFO

General

More